Mon, Sep 1, 2014, 2:39 PM EDT - U.S. Markets closed for Labor Day

Recent

% | $
Quotes you view appear here for quick access.

Zalicus Inc. Message Board

gamblevestor 1 post  |  Last Activity: Jul 15, 2014 9:53 PM Member since: Nov 26, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    1-for-10 Reverse

    by kennydong Jul 15, 2014 12:02 PM
    gamblevestor gamblevestor Jul 15, 2014 9:53 PM Flag

    Does this even have a chance to occur in 2014?
    EPIRUS is a Boston-based, privately held company, backed by Montreux Equity Partners, TPG
    Biotech, and 5AM Ventures. EPIRUS is developing a broad pipeline of biosimilars for commercialization in major emerging markets. Our first product is BOW015, a biosimilar to Remicade®. BOW015 has successfully completed P1 and P3 clinical trials. We anticipate first market approval and launch in 2014.

    Sentiment: Hold

ZLCS
1.180.00(0.00%)Jul 15 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.